{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:33:14Z","timestamp":1789155194467,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japanese Society for the Promotion of Science","doi-asserted-by":"crossref","award":["KAKENHI 18\u201306242"],"award-info":[{"award-number":["KAKENHI 18\u201306242"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18256004"],"award-info":[{"award-number":["18256004"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology,Japan","doi-asserted-by":"crossref","award":["23256002"],"award-info":[{"award-number":["23256002"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP-0906-CO"],"award-info":[{"award-number":["PIP-0906-CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PICT-2014-1579"],"award-info":[{"award-number":["PICT-2014-1579"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00430-025-00849-9","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:47:34Z","timestamp":1756896454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Leishmania pyruvate kinase and mitochondrial processing protease: Two novel vaccine candidates, selected via a seroproteomic approach, trigger a protective immune response against murine cutaneous leishmaniasis"],"prefix":"10.1007","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-8124","authenticated-orcid":false,"given":"Agust\u00edn","family":"Moya Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Arreguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Exequiel","family":"Uncos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfor Alejandro","family":"Uncos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Rodrigo","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-4128","authenticated-orcid":false,"given":"Juan Jos\u00e9","family":"Lauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3100-1432","authenticated-orcid":false,"given":"Luciana","family":"Nina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0691-492X","authenticated-orcid":false,"given":"Elvia","family":"Mej\u00eda Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6283-8579","authenticated-orcid":false,"given":"Masataka","family":"Korenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-2575","authenticated-orcid":false,"given":"Paola Andrea","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-0941","authenticated-orcid":false,"given":"Jorge Diego","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"issue":"6","key":"849_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1600-0560.2011.01844.x","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin J, Louzir H (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7(6):581\u2013596. https:\/\/doi.org\/10.1111\/j.1600-0560.2011.01844.x","journal-title":"Lancet Infect Dis"},{"key":"849_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671","author":"J Alvar","year":"2012","unstructured":"Alvar J et al (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PLoS ONE"},{"issue":"9","key":"849_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri.2016.72","volume":"16","author":"P Scott","year":"2016","unstructured":"Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16(9):581\u2013592. https:\/\/doi.org\/10.1038\/nri.2016.72","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"849_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","volume":"23","author":"HJC de Vries","year":"2022","unstructured":"de Vries HJC, Schallig HD (2022) Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol 23(6):823\u2013840. https:\/\/doi.org\/10.1007\/s40257-022-00726-8","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"849_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2334-12-191","volume":"12","author":"JD Marco","year":"2012","unstructured":"Marco JD et al (2012) Polymorphism-specific PCR enhances the diagnostic performance of American tegumentary leishmaniasis and allows the rapid identification of Leishmania species from Argentina. BMC Infect Dis 12(1):191. https:\/\/doi.org\/10.1186\/1471-2334-12-191","journal-title":"BMC Infect Dis"},{"key":"849_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.actatropica.2015.11.008","volume":"154","author":"MF Garc\u00eda Bustos","year":"2016","unstructured":"Garc\u00eda Bustos MF et al (2016) Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases. Acta Trop 154:125\u2013132. https:\/\/doi.org\/10.1016\/j.actatropica.2015.11.008","journal-title":"Acta Trop"},{"issue":"1","key":"849_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13071-016-1413-9","volume":"9","author":"C Loeuillet","year":"2016","unstructured":"Loeuillet C, Ba\u00f1uls A-L, Hide M (2016) Study of Leishmania pathogenesis in mice: experimental considerations. Parasit Vectors 9(1):144. https:\/\/doi.org\/10.1186\/s13071-016-1413-9","journal-title":"Parasit Vectors"},{"issue":"1","key":"849_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0036-46652014000100001","volume":"56","author":"EN Lor\u00eda-Cervera","year":"2014","unstructured":"Lor\u00eda-Cervera EN, Andrade-Narv\u00e1ez FJ (2014) Animal models for the study of leishmaniasis immunology. Rev Inst Med Trop Sao Paulo 56(1):1\u201311. https:\/\/doi.org\/10.1590\/S0036-46652014000100001","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"849_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:1\u201317. https:\/\/doi.org\/10.3389\/fimmu.2014.00520","journal-title":"Front Immunol"},{"issue":"12","key":"849_CR10","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","volume":"167","author":"JE Uzonna","year":"2001","unstructured":"Uzonna JE, Wei G, Yurkowski D, Bretscher P (2001) Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol 167(12):6967\u20136974. https:\/\/doi.org\/10.4049\/jimmunol.167.12.6967","journal-title":"J Immunol"},{"issue":"no. 2","key":"849_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jmii.2015.05.007","volume":"50","author":"M Rostamian","year":"2017","unstructured":"Rostamian M, Sohrabi S, Kavosifard H, Niknam HM (2017) Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB\/c mice. J Microbiol Immunol Infect 50(2):160\u2013166. https:\/\/doi.org\/10.1016\/j.jmii.2015.05.007","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"849_CR12","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","volume":"70","author":"RN Coler","year":"2002","unstructured":"Coler RN et al (2002) Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis. Infect Immun 70(8):4215\u20134225","journal-title":"Infect Immun"},{"issue":"7","key":"849_CR13","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s00436-018-5915-6","volume":"117","author":"N Mortazavidehkordi","year":"2018","unstructured":"Mortazavidehkordi N et al (2018) A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB\/C. Parasitol Res 117(7):2265\u20132273. https:\/\/doi.org\/10.1007\/s00436-018-5915-6","journal-title":"Parasitol Res"},{"key":"849_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-04289-7","author":"S Salari","year":"2020","unstructured":"Salari S, Sharifi I, Keyhani AR, Ghasemi P, Almani N (2020) Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB \/ c mice. Parasit Vectors. https:\/\/doi.org\/10.1186\/s13071-020-04289-7","journal-title":"Parasit Vectors"},{"key":"849_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01526","author":"CMC Rodrigues","year":"2020","unstructured":"Rodrigues CMC, Plotkin SA (2020) Impact of vaccines; health, economic and social perspectives. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.01526","journal-title":"Front Microbiol"},{"issue":"3","key":"849_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","volume":"95","author":"P Desjeux","year":"2001","unstructured":"Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95(3):239\u2013243. https:\/\/doi.org\/10.1016\/S0035-9203(01)90223-8","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"849_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4269\/AJTMH.15-0408","volume":"94","author":"I Okwor","year":"2016","unstructured":"Okwor I, Uzonna J (2016) Social and economic burden of human leishmaniasis. Am J Trop Med Hyg 94(3):489. https:\/\/doi.org\/10.4269\/AJTMH.15-0408","journal-title":"Am J Trop Med Hyg"},{"key":"849_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0009003","volume":"34","author":"MF Garc\u00eda-Bustos","year":"2021","unstructured":"Garc\u00eda-Bustos MF et al (2021) Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina. PLoS Negl Trop Dis 34:1\u201317. https:\/\/doi.org\/10.1371\/journal.pntd.0009003","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"849_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.4269\/ajtmh.2005.72.606","volume":"72","author":"JD Marco","year":"2005","unstructured":"Marco JD et al (2005) Species assignation of Leishmania from human and canine American tegumentary leishmaniasis cases by multilocus enzyme electrophoresis in north Argentina. Am J Trop Med Hyg 72(5):606\u2013611. https:\/\/doi.org\/10.4269\/ajtmh.2005.72.606","journal-title":"Am J Trop Med Hyg"},{"key":"849_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232829","author":"ME Bracamonte","year":"2020","unstructured":"Bracamonte ME et al (2020) High performance of an enzyme linked immunosorbent assay for American tegumentary leishmaniasis diagnosis with Leishmania (Viannia) braziliensis amastigotes membrane crude antigens. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0232829","journal-title":"PLoS ONE"},{"key":"849_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.06.597691v1.abstract","author":"S Heeren","year":"2024","unstructured":"Heeren S et al (2024) Evolutionary genomics of a zoonotic parasite across the Neotropical Realm. bioRxiv. https:\/\/doi.org\/10.1101\/2024.06.06.597691v1.abstract","journal-title":"bioRxiv"},{"issue":"4","key":"849_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/21645515.2019.1678998","volume":"16","author":"B Coutinho De Oliveira","year":"2019","unstructured":"Coutinho De Oliveira B, Duthie MS, Alves Pereira VR (2019) Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis. Hum Vaccines Immunother 16(4):919\u2013930. https:\/\/doi.org\/10.1080\/21645515.2019.1678998","journal-title":"Hum Vaccines Immunother"},{"issue":"2","key":"849_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.imbio.2016.09.015","volume":"222","author":"MC Duarte","year":"2017","unstructured":"Duarte MC et al (2017) A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection. Immunobiology 222(2):251\u2013260. https:\/\/doi.org\/10.1016\/j.imbio.2016.09.015","journal-title":"Immunobiology"},{"key":"849_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001610","author":"R Gomes","year":"2012","unstructured":"Gomes R et al (2012) KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi. PLoS Negl Trop Dis. https:\/\/doi.org\/10.1371\/journal.pntd.0001610","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"849_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1128\/CVI.00060-07","volume":"14","author":"G Salay","year":"2007","unstructured":"Salay G et al (2007) Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the new world. Clin Vaccine Immunol 14(9):1173\u20131181. https:\/\/doi.org\/10.1128\/CVI.00060-07","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"849_CR26","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1128\/IAI.71.11.6270-6278.2003","volume":"71","author":"K Campbell","year":"2003","unstructured":"Campbell K, Diao H, Ji J, Soong L (2003) DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous leishmaniasis DNA immunization with the gene encoding P4 nuclease of leishmania amazonensis protects mice against cutaneous leishmaniasis. Infect Immun 71(11):6270\u20136278. https:\/\/doi.org\/10.1128\/IAI.71.11.6270-6278.2003","journal-title":"Infect Immun"},{"issue":"no. 2","key":"849_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.exppara.2009.09.003","volume":"124","author":"CEC Fedeli","year":"2010","unstructured":"Fedeli CEC et al (2010) Partial protective responses induced by a recombinant cysteine proteinase from Leishmania (Leishmania) amazonensis in a murine model of cutaneous leishmaniasis. Exp Parasitol 124(2):153\u2013158. https:\/\/doi.org\/10.1016\/j.exppara.2009.09.003","journal-title":"Exp Parasitol"},{"key":"849_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/695432","author":"AM Montalvo-\u00c1lvarez","year":"2008","unstructured":"Montalvo-\u00c1lvarez AM, Folgueira C, Carri\u00f3n J, Monzote-Fidalgo L, Ca\u00f1avate C, Requena JM (2008) The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB\/c mice against experimental L. amazonensis infection. J Biomed Biotechnol. https:\/\/doi.org\/10.1155\/2008\/695432","journal-title":"J Biomed Biotechnol"},{"issue":"no. 8","key":"849_CR29","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","volume":"166","author":"S M\u00e9ndez","year":"2001","unstructured":"M\u00e9ndez S et al (2001) The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J Immunol 166(8):5122\u20135128. https:\/\/doi.org\/10.4049\/jimmunol.166.8.5122","journal-title":"J Immunol"},{"issue":"20","key":"849_CR30","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/s0264-410x(98)00075-9","volume":"16","author":"A Sj\u00f6lander","year":"1998","unstructured":"Sj\u00f6lander A, Baldwin TM, Curtis JM, Bengtsson KL, Handman E (1998) Vaccination with recombinant parasite surface antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection. Vaccine 16(20):2077\u20132084. https:\/\/doi.org\/10.1016\/s0264-410x(98)00075-9","journal-title":"Vaccine"},{"issue":"7","key":"849_CR31","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","volume":"66","author":"JR Webb","year":"1998","unstructured":"Webb JR et al (1998) Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect Immun 66(7):3279\u20133289. https:\/\/doi.org\/10.1128\/IAI.66.7.3279-3289.1998","journal-title":"Infect Immun"},{"issue":"9\u201310","key":"849_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S0264-410X(99)00340-0","volume":"18","author":"N Solioz","year":"1999","unstructured":"Solioz N et al (1999) The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis. Vaccine 18(9\u201310):850\u2013859. https:\/\/doi.org\/10.1016\/S0264-410X(99)00340-0","journal-title":"Vaccine"},{"issue":"3","key":"849_CR33","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1128\/IAI.68.3.1498-1506.2000","volume":"68","author":"N Soussi","year":"2000","unstructured":"Soussi N, Milon G, Colle JH, Mougneau E, Glaichenhaus N, Goossens PL (2000) Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36\/LACK antigen of Leishmania major. Infect Immun 68(3):1498\u20131506. https:\/\/doi.org\/10.1128\/IAI.68.3.1498-1506.2000","journal-title":"Infect Immun"},{"issue":"5","key":"849_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00273","volume":"5","author":"D Nico","year":"2014","unstructured":"Nico D, Gomes DC, Palatnik-de-Sousa I, Morrot A, Palatnik M, Palatnik-de-Sousa CB (2014) Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection. Front Immunol 5(5):1\u201312. https:\/\/doi.org\/10.3389\/fimmu.2014.00273","journal-title":"Front Immunol"},{"issue":"6","key":"849_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran B, Arunachalam PS, O\u2019Hagan DT (2021) Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov 20(6):454\u2013475. https:\/\/doi.org\/10.1038\/s41573-021-00163-y","journal-title":"Nat Rev Drug Discov"},{"issue":"49","key":"849_CR36","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1016\/j.vaccine.2019.09.067","volume":"37","author":"J Vitoriano-souza","year":"2019","unstructured":"Vitoriano-souza J et al (2019) Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and incomplete Freund\u2019 s adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation. Vaccine 37(49):7269\u20137279. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.067","journal-title":"Vaccine"},{"issue":"2","key":"849_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/vaccines11020395","volume":"11","author":"FAS Mathias","year":"2023","unstructured":"Mathias FAS et al (2023) The use of an adjuvant system improves innate and adaptive immune response when associated with a Leishmania (Viannia) braziliensis antigen in a vaccine candidate against L. (Leishmania) infantum infection. Vaccines 11(2):395. https:\/\/doi.org\/10.3390\/vaccines11020395","journal-title":"Vaccines"},{"issue":"2","key":"849_CR38","first-page":"573","volume":"15","author":"M Tafaghodi","year":"2016","unstructured":"Tafaghodi M, Eskandari M, Khamesipour A, Jaafaric MR (2016) Immunization against cutaneous Leishmaniasis by alginate microspheres loaded with autoclaved Leishmania major (ALM) and Quillaja saponins. Iran J Pharm Res 15(2):573\u2013581","journal-title":"Iran J Pharm Res"},{"issue":"2","key":"849_CR39","first-page":"178","volume":"19","author":"A Mehravaran","year":"2016","unstructured":"Mehravaran A et al (2016) The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB\/c mice. Iran J Basic Med Sci 19(2):178\u2013186","journal-title":"Iran J Basic Med Sci"},{"issue":"10","key":"849_CR40","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1017\/S0031182015000724","volume":"142","author":"LE Costa","year":"2015","unstructured":"Costa LE et al (2015) Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection. Parasitology 142(10):1335\u20131347. https:\/\/doi.org\/10.1017\/S0031182015000724","journal-title":"Parasitology"},{"key":"849_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2016.12.008","volume":"313","author":"VT Martins","year":"2017","unstructured":"Martins VT et al (2017) A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection. Cell Immunol 313:32\u201342. https:\/\/doi.org\/10.1016\/j.cellimm.2016.12.008","journal-title":"Cell Immunol"},{"issue":"3","key":"849_CR42","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1128\/iai.68.3.1328-1336.2000","volume":"68","author":"T Aebischer","year":"2000","unstructured":"Aebischer T, Wolfram M, Patzer SI, Ilg T, Wiese M, Overath P (2000) Subunit vaccination of mice against New World cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants. Infect Immun 68(3):1328\u20131336. https:\/\/doi.org\/10.1128\/iai.68.3.1328-1336.2000","journal-title":"Infect Immun"},{"issue":"2","key":"849_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines13020129","volume":"13","author":"MF de Mello","year":"2025","unstructured":"de Mello MF et al (2025) Efficacy of LaAg vaccine associated with saponin against Leishmania amazonensis infection. Vaccines 13(2):1\u201318. https:\/\/doi.org\/10.3390\/vaccines13020129","journal-title":"Vaccines"},{"issue":"APR","key":"849_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00069","volume":"3","author":"CB Palatnik-de-Sousa","year":"2012","unstructured":"Palatnik-de-Sousa CB (2012) Vaccines for canine leishmaniasis. Front Immunol 3(APR):1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2012.00069","journal-title":"Front Immunol"},{"key":"849_CR45","unstructured":"ClinicalTrials, NLM, and NIH, \u201cClinical Trials: Cutaneous Leishmaniasis + Vaccine,\u201d 2023. https:\/\/clinicaltrials.gov\/ct2\/results?cond=Cutaneous+Leishmaniases%26term=vaccine%26cntry=%26state=%26city=%26dist= (Accessed Mar. 30, 2023)"},{"key":"849_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.meegid.2014.12.031","volume":"30","author":"JD Marco","year":"2015","unstructured":"Marco JD et al (2015) Multilocus sequence typing approach for a broader range of species of Leishmania genus: describing parasite diversity in Argentina. Infect Genet Evol 30:308\u2013317. https:\/\/doi.org\/10.1016\/j.meegid.2014.12.031","journal-title":"Infect Genet Evol"},{"issue":"3","key":"849_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4269\/ajtmh.2004.71.297","volume":"71","author":"R Porrozzi","year":"2004","unstructured":"Porrozzi R, Teva A, Amaral VF, Santos Da Costa MV, Grimaldi G (2004) Cross-immunity experiments between different species or strains of Leishmania in Rhesus macaques (Macaca mulatta). Am J Trop Med Hyg 71(3):297\u2013305","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"849_CR48","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.vaccine.2012.11.032","volume":"31","author":"KM Bacon","year":"2013","unstructured":"Bacon KM et al (2013) The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. Vaccine 31(3):480\u2013486. https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.032","journal-title":"Vaccine"},{"issue":"11","key":"849_CR49","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1128\/CVI.00465-15","volume":"22","author":"MC Duarte","year":"2015","unstructured":"Duarte MC et al (2015) Proteins selected in Leishmania (Viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis. Clin Vaccine Immunol 22(11):1187\u20131196. https:\/\/doi.org\/10.1128\/CVI.00465-15","journal-title":"Clin Vaccine Immunol"},{"key":"849_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2021.108065","author":"S Heidari","year":"2021","unstructured":"Heidari S et al (2021) Identification of immunodominant proteins of Leishmania infantum by immunoproteomics to evaluate a recombinant multi-epitope designed antigen for serodiagnosis of human visceral leishmaniasis. Exp Parasitol. https:\/\/doi.org\/10.1016\/j.exppara.2021.108065","journal-title":"Exp Parasitol"},{"issue":"1","key":"849_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0001430","volume":"6","author":"VTS Coelho","year":"2012","unstructured":"Coelho VTS et al (2012) Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. PLoS Negl Trop Dis 6(1):1\u201310. https:\/\/doi.org\/10.1371\/journal.pntd.0001430","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"849_CR52","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1021\/pr101286y","volume":"10","author":"MM Costa","year":"2011","unstructured":"Costa MM et al (2011) Analysis of Leishmania chagasi by 2-D difference gel eletrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine. J Proteome Res 10(5):2172\u20132184. https:\/\/doi.org\/10.1021\/pr101286y","journal-title":"J Proteome Res"},{"issue":"8","key":"849_CR53","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1021\/pr100048m","volume":"9","author":"MC Brotherton","year":"2010","unstructured":"Brotherton MC, Racine G, Foucher AL, Drummelsmith J, Papadopoulou B, Ouellette M (2010) Analysis of stage-specific expression of basic proteins in Leishmania infantum. J Proteome Res 9(8):3842\u20133853. https:\/\/doi.org\/10.1021\/pr100048m","journal-title":"J Proteome Res"},{"issue":"2","key":"849_CR54","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1096\/fj.07-9254com","volume":"22","author":"D Rosenzweig","year":"2008","unstructured":"Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, Zilberstein D (2008) Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 22(2):590\u2013602. https:\/\/doi.org\/10.1096\/fj.07-9254com","journal-title":"FASEB J"},{"key":"849_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-9-255","volume":"9","author":"A Rochette","year":"2008","unstructured":"Rochette A et al (2008) Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species. BMC Genomics 9:1\u201326. https:\/\/doi.org\/10.1186\/1471-2164-9-255","journal-title":"BMC Genomics"},{"key":"849_CR56","doi-asserted-by":"publisher","DOI":"10.1017\/S003118201600024X","author":"LG Velasquez","year":"2016","unstructured":"Velasquez LG et al (2016) Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB \/ c, BALB \/ c nude and C57BL \/ 6 mice. Parasitology. https:\/\/doi.org\/10.1017\/S003118201600024X","journal-title":"Parasitology"},{"issue":"12","key":"849_CR57","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0020-7519(03)00179-6","volume":"33","author":"N Courret","year":"2003","unstructured":"Courret N, Lang T, Milon G, Antoine JC (2003) Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB\/c mice. Int J Parasitol 33(12):1373\u20131383. https:\/\/doi.org\/10.1016\/S0020-7519(03)00179-6","journal-title":"Int J Parasitol"},{"issue":"7","key":"849_CR58","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ng2053","volume":"39","author":"CS Peacock","year":"2007","unstructured":"Peacock CS et al (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39(7):839\u2013847. https:\/\/doi.org\/10.1038\/ng2053","journal-title":"Nat Genet"},{"issue":"MAY","key":"849_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2014.00189","volume":"5","author":"D Nico","year":"2014","unstructured":"Nico D et al (2014) Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania donovani nucleoside hydrolase terminal domains. Front Immunol 5(MAY):1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2014.00189","journal-title":"Front Immunol"},{"issue":"1","key":"849_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chom.2017.06.006","volume":"22","author":"C Gimblet","year":"2017","unstructured":"Gimblet C et al (2017) Cutaneous leishmaniasis induces a transmissible dysbiotic skin microbiota that promotes skin article cutaneous leishmaniasis induces a transmissible dysbiotic skin microbiota that promotes skin inflammation. Cell Host Microbe 22(1):13-24.e4. https:\/\/doi.org\/10.1016\/j.chom.2017.06.006","journal-title":"Cell Host Microbe"},{"key":"849_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12030310","author":"F Avenda\u00f1o-Rangel","year":"2024","unstructured":"Avenda\u00f1o-Rangel F et al (2024) Immunization with centrin-deficient Leishmania braziliensis does not protect against homologous challenge. Vaccines. https:\/\/doi.org\/10.3390\/vaccines12030310","journal-title":"Vaccines"},{"issue":"6","key":"849_CR62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2019.04.002","volume":"35","author":"LS Hohman","year":"2019","unstructured":"Hohman LS, Peters NC (2019) CD4+ T cell-mediated immunity against the phagosomal pathogen Leishmania: implications for vaccination. Trends Parasitol 35(6):423\u2013435. https:\/\/doi.org\/10.1016\/j.pt.2019.04.002","journal-title":"Trends Parasitol"},{"key":"849_CR63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2018.12.013","volume":"106","author":"FD R\u00eago","year":"2018","unstructured":"R\u00eago FD, Fradico JRB, Teixeira-Carvalho A, Gontijo CMF (2018) Molecular variants of Leishmania (Viannia) braziliensis trigger distinct patterns of cytokines and chemokines expression in golden hamster. Mol Immunol 106:36\u201345. https:\/\/doi.org\/10.1016\/j.molimm.2018.12.013","journal-title":"Mol Immunol"},{"issue":"1","key":"849_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56305-1","volume":"10","author":"JI Aoki","year":"2019","unstructured":"Aoki JI, Muxel SM, Zampieri RA, M\u00fcller KE, Nerland AH, Floeter-Winter LM (2019) Differential immune response modulation in early Leishmania amazonensis infection of BALB\/c and C57BL\/6 macrophages based on transcriptome profiles. Sci Rep 10(1):1\u201314. https:\/\/doi.org\/10.1038\/s41598-019-56305-1","journal-title":"Sci Rep"},{"issue":"12","key":"849_CR65","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/S00436-023-07981-6","volume":"122","author":"MM Jesus","year":"2023","unstructured":"Jesus MM et al (2023) Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis. Parasitol Res 122(12):2917\u20132931. https:\/\/doi.org\/10.1007\/S00436-023-07981-6","journal-title":"Parasitol Res"},{"issue":"6","key":"849_CR66","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.191.6.1063","volume":"191","author":"PE Kima","year":"2000","unstructured":"Kima PE et al (2000) Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 191(6):1063\u20131067. https:\/\/doi.org\/10.1084\/jem.191.6.1063","journal-title":"J Exp Med"},{"issue":"1","key":"849_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpara.2007.08.010","volume":"23","author":"N Wanasen","year":"2008","unstructured":"Wanasen N, Xin L, Soong L (2008) Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol 23(1):1\u20137. https:\/\/doi.org\/10.1016\/j.ijpara.2007.08.010","journal-title":"Int J Parasitol"},{"issue":"no. 7","key":"849_CR68","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","volume":"186","author":"S Gurunathan","year":"1997","unstructured":"Gurunathan S et al (1997) Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med 186(7):1137\u20131147. https:\/\/doi.org\/10.1084\/jem.186.7.1137","journal-title":"J Exp Med"},{"issue":"1","key":"849_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1021\/ACSPTSCI.4C00341","volume":"8","author":"JE da Cruz Freire","year":"2024","unstructured":"da Cruz Freire JE et al (2024) Molecular and immunological properties of a chimeric glycosyl hydrolase 18 based on immunoinformatics approaches: a design of a new anti-Leishmania vaccine. ACS Pharmacol Transl Sci 8(1):78\u201396. https:\/\/doi.org\/10.1021\/ACSPTSCI.4C00341","journal-title":"ACS Pharmacol Transl Sci"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00849-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-025-00849-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00849-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:56:55Z","timestamp":1767095815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-025-00849-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["849"],"URL":"https:\/\/doi.org\/10.1007\/s00430-025-00849-9","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests, directly or indirectly related to the work submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"41"}}